Yeon Hee Park

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Real-world Treatment Outcomes and Safety of Neoadjuvant Pembrolizumab-containing Therapy in Patients With Triple-negative Breast Cancer: Korean Nationwide Multicenter Study (Pembro-Real World)	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Not yet recruiting	Not stated	2026-09-18	NCT07828652
NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd	Patients With HER2-low Advanced Breast Cancer Treated With T-DXd; Patients With HER2-positive Advanced Breast Cancer Treated With T-DXd	Enrolling by invitation	Not stated	2026-01-08	NCT07132749
Fulvestrant With Ribociclib Versus Physician's Choice Treatments Recurred After Completion of Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in HR+, HER2- Metastatic Breast Cancer	Breast Cancer Metastatic	Not yet recruiting	Phase 2	2025-12-24	NCT06849947
Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer	Breast Cancer Metastatic	Recruiting	Phase 2	2025-08-28	NCT06616987

Clinical trials